KBC Group’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-232,052
| Closed | -$42.6M | – | 1349 |
|
|
2021
Q2 | $42.6M | Sell |
232,052
-80,596
| -26% | -$13.8M | 0.08% | 253 |
|
|
2021
Q1 | $47.8M | Buy |
312,648
+13,702
| +5% | +$2.12M | 0.1% | 235 |
|
|
2020
Q4 | $257M | Buy |
298,946
+116,808
| +64% | +$15M | 0.11% | 206 |
|
|
2020
Q3 | $20.8M | Buy |
182,138
+51,552
| +39% | +$5.56M | 0.06% | 285 |
|
|
2020
Q2 | $14.7M | Buy |
130,586
+71,375
| +121% | +$7.58M | 0.05% | 324 |
|
|
2020
Q1 | $5.32M | Sell |
59,211
-539
| -0.9% | -$52.9K | 0.04% | 365 |
|
|
2019
Q4 | $6.46M | Buy |
59,750
+923
| +2% | +$98.7K | 0.04% | 408 |
|
|
2019
Q3 | $5.76M | Buy |
58,827
+1,513
| +3% | +$171K | 0.04% | 422 |
|
|
2019
Q2 | $7.51M | Hold |
57,314
| – | – | 0.06% | 361 |
|
|
2019
Q1 | $7.75M | Sell |
57,314
-4,483
| -7% | -$557K | 0.06% | 341 |
|
|
2018
Q4 | $6.02M | Sell |
61,797
-135,389
| -69% | -$16M | 0.07% | 312 |
|
|
2018
Q3 | $27.4M | Buy |
197,186
+55,794
| +39% | +$7M | 0.21% | 127 |
|
|
2018
Q2 | $17.6M | Buy |
141,392
+113,522
| +407% | +$13.3M | 0.15% | 181 |
|
|
2018
Q1 | $3.11M | Buy |
27,870
+7,316
| +36% | +$874K | 0.03% | 481 |
|
|
2017
Q4 | $2.46M | Sell |
20,554
-6,373
| -24% | -$776K | 0.02% | 540 |
|
|
2017
Q3 | $3.78M | Sell |
26,927
-3,018
| -10% | -$410K | 0.03% | 453 |
|
|
2017
Q2 | $3.64M | Sell |
29,945
-112,361
| -79% | -$13.1M | 0.04% | 450 |
|
|
2017
Q1 | $17.3M | Buy |
142,306
+53,666
| +61% | +$6.92M | 0.16% | 160 |
|
|
2016
Q4 | $10.8M | Buy |
88,640
+68,732
| +345% | +$8.41M | 0.11% | 237 |
|
|
2016
Q3 | $2.44M | Buy |
19,908
+903
| +5% | +$116K | 0.03% | 525 |
|
|
2016
Q2 | $2.22M | Sell |
19,005
-22,758
| -54% | -$3.23M | 0.03% | 513 |
|
|
2016
Q1 | $5.81M | Buy |
41,763
+1,465
| +4% | +$215K | 0.1% | 260 |
|
|
2015
Q4 | $7.69M | Buy |
40,298
+18,160
| +82% | +$3.17M | 0.14% | 179 |
|
|
2015
Q3 | $3.46M | Buy |
22,138
+7,045
| +47% | +$1.29M | 0.07% | 317 |
|
|
2015
Q2 | $2.73M | Sell |
15,093
-17,596
| -54% | -$3.04M | 0.04% | 460 |
|
|
2015
Q1 | $5.67M | Sell |
32,689
-22,515
| -41% | -$4.08M | 0.07% | 287 |
|
|
2014
Q4 | $10.2M | Buy |
55,204
+34,567
| +168% | +$6.41M | 0.12% | 202 |
|
|
2014
Q3 | $3.42M | Sell |
20,637
-71,937
| -78% | -$11.8M | 0.12% | 237 |
|
|
2014
Q2 | $14.5M | Buy |
92,574
+60,924
| +192% | +$9.62M | 0.17% | 152 |
|
|
2014
Q1 | $4.82M | Sell |
31,650
-24,910
| -44% | -$3.96M | 0.08% | 306 |
|
|
2013
Q4 | $7.52M | Buy |
56,560
+10,777
| +24% | +$1.29M | 0.11% | 239 |
|
|
2013
Q3 | $5.32M | Sell |
45,783
-34,315
| -43% | -$3.76M | 0.09% | 295 |
|
|
2013
Q2 | $7.39M | Buy |
+80,098
| New | +$7.72M | 0.14% | 190 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM